What are some opinions on the ethics of CRISPR? “Doudna herself recognizes that CRISPR carries with it “great risk….but she warned of the unknown consequences of embryo editing, cautioning researchers to wait to use CRISPR for these ends.”

What does the future of human genomics and equity look like? “This special issue of Nature examines how far the human genome sequence has taken us, and how far we have to go.”

What drives vaccine hesitancy among healthcare workers? “The hesitancy is less outright rejection than cautious skepticism. It’s driven by suspicions about the evidence supporting the new vaccines and about the motives of those endorsing them.”

How can we look to the past to provide insight into our current society? In this piece by Jenny Gross, we take a look at historical mass vaccination campaigns and how past questions can now lead to future answers.

Vaccine hesitancy has been an important topic for discussion regarding the #COVID19 vaccine. “How can medical and public health leaders work to overcome this hesitancy? To start with, acknowledge the historical reasons for black mistrust of medicine.”

A big component of vaccine distribution has been utilizing ethics to determine vaccine prioritization. Issac Chotiner of The New Yorker speaks with immunologist Barry Bloom to discuss what goes into making decisions on vaccine distribution.

“The first year of the Covid-19 pandemic revealed that a country’s wealth would not spare it from the virus. Overconfidence, poor planning and ignored warnings felled the world’s richest nations. But now, money is translating into undeniable advantages.”

The new COVID-19 variants that have popped up in the United Kingdom and South Africa are the new obstacles to tackle in the pandemic. Will current vaccines be able to measure up against new strains? Scientists are seeking an answer.

Why has vaccine distribution fallen into disarray across the United States? Lack of funding and coordination between state and local governments has left citizens confused about their vaccination opportunities. What will come in year 2 of COVID-19?

Recent data has shown COVID-19 numbers are trending in the wrong directions for our populations at risk. With the vaccine soon to be rolled out, what needs to be considered in distribution as we look at the effects of COVID-19 on elderly populations?